FIELD: chemical-pharmaceutical industry.
SUBSTANCE: invention relates to the chemical-pharmaceutical industry and is a means of chondroprotective action for stimulating the processes of regeneration and slowing down the degeneration of the cartilaginous tissue, including active substances, in terms of 1 capsule: glucosamine sulfate – 200.0 mg; chondroitin sulfate – 180.0 mg; collagen 20.0 mg; concentrate of milk protein – 30.0 mg; extract of boswellia – 20.0 mg.
EFFECT: invention provides a combined and synergistic action of the components described above which have a reductive effect on the musculoskeletal system and provide stimulation of regeneration processes and slowing down the degeneration of the cartilaginous tissue.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
DIETARY SUPPLEMENT WITH CHONDROPROTECTIVE ACTION AND METHOD OF ITS USE | 2022 |
|
RU2813567C1 |
COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS AND OSTEOARTHROSIS | 2011 |
|
RU2509569C2 |
SPECIALISED PRODUCT FOR SPORTSPEOPLE ALIMENTATION | 2011 |
|
RU2463811C1 |
COMBINATION OF A CHONDROPROTECTIVE AGENT WITH AN NSAID | 2017 |
|
RU2742172C2 |
FUNCTIONAL FOOD FOR JOINT AND LIGAMENT HEALTH SUPPORT | 2014 |
|
RU2564841C1 |
METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
CURATIVE-PROPHYLACTIC COMPOSITION "OSTEOMAKS-EXTRA" FOR IMPROVEMENT OF FUNCTIONAL STATE OF LOCOMOTOR SYSTEM | 2003 |
|
RU2220737C1 |
COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
COMPOSITION CONTAINING CHONDROITIN SULPHATE AND HYALURONIDASE | 2013 |
|
RU2539390C1 |
Authors
Dates
2018-03-26—Published
2016-08-01—Filed